Intas completes deal
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.
Imatinib Accord Launch
Accord Healthcare launches Imatinib Accord 100 mg and 400 mg in the UK.
Capecitabine Accord - SPC calculation clarified by CJEU
Tallinn Court of Appeal's decision has been upheld by CJEU clearing the way for Accord to launch its Capecitabine in Estonia.
Intas recent acquisition
Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland
AstraZeneca's Seroquel revocation
Spanish Supreme Court confirms revocation of AstraZeneca's Seroquel Prolong patent
EU approvals for 1Q2016
Accord product approvals received during 1Q2016.
Accord a Distinct Presence at EAHP 2016
Accord participated on the 21st edition of the European Association of Hospital Pharmacist Congress in Vienna from 16th-18th March 2016.
Aripiprazole Accord Launch
Accord Healthcare launches Aripiprazole tablets in presentations of 5, 10, 15 and 30 mg.
EU approvals for 4Q2015
Accord product approvals received during 4Q2015.